AI assistant
Sending…
USBC, Inc. — Director's Dealing 2017
Jul 7, 2017
33069_dirs_2017-07-07_1e3df88c-32d1-4b74-ac31-1a2a421125d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VISUALANT INC (VSUL)
CIK: 0001074828
Period of Report: 2017-07-06
Reporting Person: ERICKSON RONALD P (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-07-06 | Common Stock | P | 2000 | $0.23 | Acquired | 20934 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3334 | Indirect |
| Common Stock | 1467 | Indirect |
| Common Stock | 20336 | Indirect |
| Common Stock | 110001 | Indirect |
| Common Stock | 1014 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Warrant | $.15 | 2018-06-14 | Common Stock (33333) | 0 | Indirect |
| Series B Warrant | $.20 | 2018-06-14 | Common Stock (33334) | 0 | Indirect |
| Option to Purchase Common Stock | $22.50 | 2020-05-09 | Common Stock (13334) | 13334 | Direct |
| Option to Purchase Common Stock | $19.50 | 2022-06-05 | Common Stock (6667) | 6667 | Direct |
Footnotes
F1: Held by Dia Armenta, the Reporting Person's wife.
F2: Held by Ronald Erickson, the Reporting Person and Dia Armenta, the Reporting Person's wife.
F3: Held by Juliz Limited Partnership- Family LP.
F4: Held by J3E2A2Z Limited Partnership.
F5: Held by Cerillion N4, an entity that is 50% owned by Dia Armenta, the Reporting Person's wife.
F6: Option shares fully-vested quarterly over 2 years commencing 05/10/2010.
F7: Option shares fully-vested quarterly over 1 year commencing 06/05/2012.
More from USBC, Inc.
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 27
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 26
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Jan 26